The visit will primarily provide the opportunity for attendees to tour this state-of-the-art facility which serves as a global hub for the Injectables business, the largest of Hikma’s three divisions. Senior members of the Injectables team will also present on the unique fundamentals of the business, which has a solid track record of revenue growth and strong margins. No new material information will be provided.

The presentation is available on Hikma’s website - click here.